Presentation is loading. Please wait.

Presentation is loading. Please wait.

Quality and Regulatory Planning – the way forward?

Similar presentations


Presentation on theme: "Quality and Regulatory Planning – the way forward?"— Presentation transcript:

1 Quality and Regulatory Planning – the way forward?
Dr Simon Richards MEDDEV QA Ltd

2 EN ISO 13485: 2012 Top management shall ensure that
Clause Quality Management System Planning Top management shall ensure that a) the planning of the quality management system is carried out in order to meet the requirements, as well as the quality objectives, and b) the integrity of the quality management system is maintained when changes to the quality management system are planned and implemented. 

3 EN ISO 13485: 2012 Clause 5.6 - Management Review 5.6.1 General
Top management shall review the organization’s quality management system, at planned intervals, to ensure its continuing suitability, adequacy and effectiveness. This review shall include assessing opportunities for improvement and the need for changes to the quality management system, including the quality policy and quality objectives.  5.6.2 Review Input The input to management review shall include information on new or revised regulatory requirements 

4 NEW OR REVISED REGULATORY REQUIREMENTS
EN ISO 13485: 2016 – published in March (with a three year transition period)

5 NEW OR REVISED REGULATORY REQUIREMENTS
Medical Device Single Audit Program (MDSAP) - to be implemented by 1st January 2019 Medical Device Regulations - Regulation (EU) 2017/745 – published on 5th April 2017 (with a transition period to 25th May 2020) In Vitro Diagnostic Device Regulations (EU) 2017/ published on 5th April 2017 (with a transition period to 25th May 2022)

6 QUALITY AND REGULATORY PLANNING – MEDICAL DEVICE REGULATIONS
Notified Body Technical Documentation - General Safety and Performance Requirements Classification Changes Conformity Assessment Changes – More Pre-Market Authorisation leading to less predictability for review and approval timelines Unique Device Identification (UDI) Clinical Evaluations – with a greater need for Clinical Data Periodic Safety Update Reports (PSUR) Person Responsible for Regulatory Compliance Role of the Authorised Representative and Economic Operators Role of the EUDAMED Database

7 QUALITY AND REGULATORY PLANNING - IVD DEVICE REGULATIONS
Under the current IVD Directive % of IVDs require Notified Body intervention Under the IVDDR 85 – 90% of IVDs will require require Notified Body intervention

8 QUALITY AND REGULATORY PLANNING- MEDICAL DEVICE AND IVD REGULATIONS
Notified Body scrutiny of manufacturers will increase Notified Bodies will be required to have more technical and clinical expertise BUT Notified Body resources (and resource in general) will be limited Choose you Notified Body wisely and confirm their competency and available resources You may have to change Notified Body

9 BUT DO PLAN!


Download ppt "Quality and Regulatory Planning – the way forward?"

Similar presentations


Ads by Google